SEI Investments
ORKA

SEI Investments’s Oruka Therapeutics ORKA Stock Holding History

SEI Investments’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.59M Sell
16,758
-6,082
-27% -$405K ﹤0.01% 2065
2026
Q1 		$1.12M Buy
22,840
+13,164
+136% +$457K ﹤0.01% 2309
2025
Q4 		$293K Buy
+9,676
New +$270K ﹤0.01% 2755

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

SEI Investments's ORKA Position: Q2 2026 in Review

SEI Investments reduced its Oruka Therapeutics (ORKA) stake by 27% in Q2 2026, selling an estimated $405K and leaving 16,758 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #2065.

SEI Investments first reported a position in ORKA in Q4 2025 and has held it in 3 quarters since. 255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • SEI Investments held 16,758 shares of Oruka Therapeutics worth $1.59M as of Q2 2026.
  • SEI Investments sold 6,082 Oruka Therapeutics shares in Q2 2026, an estimated $405K.
  • Oruka Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2065 holding.
  • SEI Investments first reported a position in Oruka Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.